glp 1 drugs and crohn's disease SAFETY CLINICAL EFFECTIVENESS OF GLP1 AGONISTS IN INFLAMMATORY BOWEL PATIENTS GLP-1 Use in Crohn's Disease:

& Tagare, H

91 It is unclear whether the heart rate increase associated with GLP-1 RAs, which may pose a safety concern in patients with HFrEF, can be mitigated by the concurrent use of -blockers, which are typically prescribed for HFrEF

For example, research revealed the pathway by which the common gut commensal Sporosalibacterium produces the metabolite 3-phenylpropionic acid, which possesses insulin-sensitizing and antisteatotic activities

This includes: People over the age of 60 Females Patients with autoimmune conditions such as vitiligo Patients with stomach ulcers, atrophic gastritis or thinning of the lining of the stomach Digestive conditions such as Crohns disease or coeliac disease People who are vegetarian or vegan HOW DO B12 INJECTIONS HELP